脉络学说指导通络药物防治心血管疾病研究  

Research on Collateral-unblocking Medicines for Cardiovascular Diseases under the Guidance of Vessels Collateral Theory

作　　者：魏聪[1,2,3] 常丽萍 贾振华[3,5] 

机构地区：[1]中国中医科学院博士后科研流动站,北京100700 [2]河北以岭医药研究院,石家庄050035 [3]河北以岭医院国家中医药管理局中医络病学重点学科,石家庄050035 [4]河北省络病重点实验室,石家庄050035 [5]国家中医药管理局重点研究室(心脑血管络病),石家庄050035

出　　处：《中国中西医结合杂志》2015年第12期1513-1516,共4页Chinese Journal of Integrated Traditional and Western Medicine

基　　金：国家重点基础研究发展计划(973计划)(No.2012CB518606)

摘　　要：脉络学说是对《黄帝内经》"血脉"理论的传承和发展,是结合现代血管病变重大疾病提出的系统理论。本文以心血管疾病作为切入点,深入探讨脉络尤其是脉络末端的"孙络—微血管"病变在心血管疾病发生、发展中的作用和脉络学说指导下通络药物的干预效应,以期指导心血管疾病中医药的预防与治疗。Objective ＂ Vessels Collateral Theory＂,as the inherit and development of ＂ blood vessels＂ in Huangdi Neijing,is a systematic system by integrating severe vascular diseases. In this article,by taking cardiovascular diseases（ CVD） as a cut-in point,roles of ＂ minute collateral-microvascular＂ lesions in the occurrence and development of CVD were further explored. The interventional effect of collateral-unblocking medicines under the guidance of Vessels Collateral Theory was also in-depth explored,hoping to leading Chinese medical prevention and treatment of CVD.

关 键 词：脉络学说 通络药物 心血管疾病 

分 类 号：R259[医药卫生—中西医结合]